Methamphetamine

DRUG13 trials

Sponsors

University of Kentucky, Oregon Health and Science University, University of Chicago, University of California, Los Angeles, Craig Rush

Conditions

Cardiovascular AbnormalitiesDrug InteractionHealthyMDMA ('Ecstasy')Methamphetamine AbuseMethamphetamine DependenceMethamphetamine DisordersMethamphetamine Intoxication

Early Phase 1

Pilot Study of Entacapone for Methamphetamine Abuse

CompletedNCT02058966

Oregon Health and Science UniversityMethamphetamine Dependence

Start: 2014-06-30End: 2016-06-30Updated: 2019-09-12

Drugs Brain and Behavior (DDP)

CompletedNCT04642820

University of ChicagoStimulant Use

Start: 2020-11-01End: 2024-06-01Updated: 2025-01-09

Brain Function and EEG

CompletedNCT05003076

University of ChicagoHealthy, Mood

Start: 2021-07-01End: 2023-04-01Updated: 2024-01-24

Effects of Stimulants on Behavioral and Neural Markers of Social Motivation, Ability, and Neural Markers of Social Function

CompletedNCT05379959

University of ChicagoMDMA ('Ecstasy'), Motivation, Social Behavior +1

Start: 2022-05-11End: 2023-10-24Updated: 2024-01-24

Methamphetamine and Troriluzole

RecruitingNCT06989853

William StoopsMethamphetamine Use Disorder

Start: 2025-08-25End: 2029-02-28Target: 40Updated: 2025-12-23

Phase 1

Buspirone as a Candidate Medication for Methamphetamine Abuse

CompletedNCT01843205

University of KentuckyMethamphetamine Abuse, Methamphetamine Dependence

Start: 2013-04-30End: 2017-03-31Updated: 2018-02-07

Study of Pomaglumetad and Methamphetamine

TerminatedNCT03106571

University of California, Los AngelesMethamphetamine Use Disorder

Start: 2017-08-01End: 2020-07-31Updated: 2020-09-01

Effect of Stimulant Drugs on Social Perception

CompletedNCT03790618

University of ChicagoHealthy, MDMA ('Ecstasy')

Start: 2016-06-01End: 2018-08-01Updated: 2024-01-05

Behavioral Effects of Drugs (Inpatient): 40 [Methamphetamine, Methylphenidate, Duloxetine]

CompletedNCT04178993

Craig RushMethamphetamine Use Disorder

Start: 2019-09-01End: 2021-05-05Updated: 2023-01-09

Mirtazapine and Methamphetamine Drug-drug Interaction Study

CompletedNCT04614584

San Francisco Department of Public HealthCardiovascular Abnormalities, Drug Interaction, Methamphetamine Use Disorder

Start: 2021-05-03End: 2024-05-31Updated: 2024-09-27

Phase 2

MDMA-Assisted CBT for OCD (MDMA-CBT4OCD Study)

RecruitingNCT05783817

Carolyn RodriguezObsessive-Compulsive Disorder

Start: 2025-09-10End: 2026-12-01Target: 40Updated: 2026-03-05

A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine

RecruitingNCT06721494

Clear Scientific, Inc.Methamphetamine Abuse, Methamphetamine Disorders, Methamphetamine Intoxication

Start: 2026-02-05End: 2026-09-11Target: 40Updated: 2026-01-12

Unknown Phase

Acquisition of Responses to a Methamphetamine-associated Cue in Healthy Humans

CompletedNCT02323048

University of ChicagoSubstance Abuse

Start: 2014-07-31End: 2014-12-31Updated: 2018-07-26

Related Papers

MDMA enhances positive affective responses to social feedback

Journal of Psychopharmacology2024-01-277 citations